• Careers
  • News
  • Publications
  • Contact Us
  • Company
    • About Us
    • Management Team
    • Board of Directors
    • Collaborations
    • Careers
    • Contact Us
  • Therapeutic Areas
    • Oncology
    • Cystic Fibrosis
    • Publications
  • Programs
    • Pipeline
    • mTORC1/2 inhibitor Sapanisertib
    • SYK Inhibitor Mivavotinib
    • Arginase Inhibitor
      Cystic Fibrosis
    • Preclinical Programs
  • Clinical Trials
    • Clinical Trials Overview
    • Expanded Access
  • Investors
    • Corporate Profile
    • Press Releases
    • Event & Presentations
    • Stock Information
    • Financial Information
      • Overview
      • SEC Filings
      • Ownership Summary
    • Analyst Coverage
    • Corporate Governance
      • Highlights
      • Board of Directors
      • Management Team
      • Committee Composition
    • Shareholder Services
      • Investor FAQs
      • E-mail Alerts
    • Proxy & Annual Report
    • Contact Us
  • Careers
  • News
  • Publications
  • Contact Us

Company

Contact Us

Calithera Biosciences, Inc.

343 Oyster Point Blvd, Suite 200
South San Francisco, CA 94080
+1 650 870 1000

Department Representatives

Investor & Media Contact

Stephanie Wong
Chief Financial Officer

Business Development Contact

Matt Gross
Vice President of Business Development

Scientific Collaborations Contact

Jennifer Yori
Associate Director, Medical Affairs

Medical Affairs Contact

Natalie Kittrell
Head of Medical Affairs

  • About Us
  • Management Team
  • Board of Directors
  • Collaborations
  • Careers
  • Contact Us
Company
  • About Us
  • Management Team
  • Board of Directors
  • Collaborations
  • Careers
  • Contact Us
Therapeutic Areas
  • Oncology
  • Cystic Fibrosis
  • Publications
Programs
  • Pipeline
  • mTORC1/2 inhibitor Sapanisertib
  • SYK Inhibitor Mivavotinib
  • Arginase Inhibitor Cystic Fibrosis
  • Preclinical Programs
Clinical Trials
  • Clinical Trial Overview
  • Expanded Access
Investors
  • Corporate Profile
  • Press Release
  • Events & Presentations
  • Stock Information
  • Financial Information
  • Analyst Coverage
  • Corporate Governance
  • Shareholder Services
  • Proxy & Annual Report
  • Contact Us
© 2022 Calithera Biosciences, Inc. All rights reserved.
ETHICS & COMPLIANCEPRIVACY POLICYLEGAL TERMS OF USE
  • Contact Us
  • News
CALITHERA® and the Calithera logos are trademarks or registered trademarks of Calithera Biosciences, Inc.
CALITHERA® and the Calithera logos are trademarks or registered trademarks of Calithera Biosciences, Inc.